There was no difference between the BRCA1 cohort and the BRCA2 cohort and the female cohort with advanced rectal cancer (p = 0.359 and p = 0.187) as well as with the total cohort of advanced rectal cancer (p = 0.190 and p = 0.050). Here, BRCA2 is linked to rectal cancer.